China Medical Technologies
Class Action Lawsuits Filed Against China Medical Technologies Alleging Artificial Stock Inflation
NEW YORK (GenomeWeb News) – Investors are suing China Medical Technologies alleging the firm engaged in actions that artificially inflated its stock in violation of US securities law.
Beijing-based China Medical Technologies said this week that China's State Food and Drug Administration has approved its real-time PCR-based KRAS assay as a companion diagnostic test for the use of a targeted colorectal cancer drug.
China's SFDA Approves China Med Tech's Companion Dx for Colorectal Cancer
NEW YORK (GenomeWeb News) – China Medical Technologies today announced that its PCR-based KRAS assay has been approved in China as a companion diagnostic for an undisclosed drug targeting colorectal cancer.
China Med Tech, Gaoxin Da An Partner on MDx Marketing Deal
China Medical Technologies' wholly owned subsidiary Beijing GP Medical Technologies and Da An Health will co-market and promote molecular diagnostic products to hospitals in China.
China Medical Technologies Records 33 Percent Increase in MDx Revenues for Q2
Sales of its FISH probes and new HPV-DNA chips helped drive up sales in its molecular diagnostics systems segment.